ConductScience.org, home

Paper118952

The effect of diuretic pre-treatment on clinical, morphological and ultrastructural cis-platinum induced nephrotoxicity.

Lehane D and 3 others. Int J Radiat Oncol Biol Phys, 1979. Cited by 59 papers, by iCite.

Cite this record

ConductScience Library. The effect of diuretic pre-treatment on clinical, morphological and ultrastructural cis-platinum induced nephrotoxicity. Papers, record 118952. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/118952

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The effect of diuretic pre-treatment on clinical, morphological and ultrastructural cis-platinum induced nephrotoxicity.
PubMed
Journal
Int J Radiat Oncol Biol Phys
PubMed
Year
1979
PubMed
Publication types
Comparative Study, Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
59
iCite
Relative citation ratio, by iCite
2.21
iCite
Revised in PubMed
2022-04-08
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lehane DD
2Winston AA
3Gray RR
4Daskal YY

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CisplatinMajor topic
DiureticsMajor topic
KidneyMajor topic
Animals
Furosemide
Male
Mannitol
Microscopy, Electron
Rats

Source PubMed

Download CSV of topics

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 59 citations.

PMIDTitleJournalYearIn PapersSource
38714773Comparison of preventive effects of combined furosemide and mannitol versus single diuretics, furosemide or mannitol, on cisplatin-induced nephrotoxicity.Sci Rep2024https://conductscience.org/library/papers/38714773PubMed
34646321Hydration with Mannitol and Dextrose May Promote Cisplatin-Induced Nephrotoxicity: Test of Five Protocols of Hydration during Cisplatin Therapy in Rat Models.J Toxicol2021https://conductscience.org/library/papers/34646321PubMed
32039012Treating Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck Unsuitable to Receive Cisplatin-Based Therapy.Front Oncol2019https://conductscience.org/library/papers/32039012PubMed
31817713Paradoxical Effect of Grape Pomace Extract on Cisplatin-Induced Acute Kidney Injury in Rats.Pharmaceutics2019https://conductscience.org/library/papers/31817713PubMed
31223570The Prevalence of the Potential Drug-Drug Interactions Involving Anticancer Drugs in China: A Retrospective Study.Iran J Public Health2019https://conductscience.org/library/papers/31223570PubMed
31049108The Assessment of Drug Utilization Study of Anticancer Drugs Using WHO Prescribing Indicators in a Government Tertiary Care Hospital of the Hyderabad - Karnataka Region of India.Open Access Maced J Med Sci2019https://conductscience.org/library/papers/31049108PubMed
30646560Protective Smell of Hydrogen Sulfide and Polysulfide in Cisplatin-Induced Nephrotoxicity.Int J Mol Sci2019https://conductscience.org/library/papers/30646560PubMed
30167970Evaluation of the effect of acetazolamide versus mannitol on cisplatin-induced nephrotoxicity, a pilot study.Int J Clin Pharm2018https://conductscience.org/library/papers/30167970PubMed
23205279Hydration with magnesium and mannitol without furosemide prevents the nephrotoxicity induced by cisplatin and pemetrexed in patients with advanced non-small cell lung cancer.J Thorac Dis2012https://conductscience.org/library/papers/23205279PubMed
22069563Mechanisms of Cisplatin nephrotoxicity.Toxins (Basel)2010https://conductscience.org/library/papers/22069563PubMed
11710838Nucleolar damage correlates with neurotoxicity induced by different platinum drugs.Br J Cancer2001https://conductscience.org/library/papers/11710838PubMed
8174197Factors affecting human autopsy kidney-cortex and kidney-medulla platinum concentrations after cisplatin administration.Cancer Chemother Pharmacol1994https://conductscience.org/library/papers/8174197PubMed
7987972Cisplatin-induced renal toxicity and toxicity-modulating strategies: a review.Cancer Chemother Pharmacol1994https://conductscience.org/library/papers/7987972PubMed
7199350Proliferative defects in renal and intestinal epithelium after cis-dichlorodiammine platinum (II).Br J Cancer1982https://conductscience.org/library/papers/7199350PubMed
6428763Effects of the diuretics mannitol or acetazolamide on nephrotoxicity and physiological disposition of cisplatin in rats.Cancer Chemother Pharmacol1984https://conductscience.org/library/papers/6428763PubMed
4040218Attenuation of cisplatinum-induced nephrotoxicity in the rat by high salt diet, furosemide and acetazolamide.Naunyn Schmiedebergs Arch Pharmacol1985https://conductscience.org/library/papers/4040218PubMed
3542269Urinary beta 2-microglobulin: early indicator of high dose cisdiamminedichloroplatinum nephrotoxicity? Influence of furosemide.Cancer Chemother Pharmacol1986https://conductscience.org/library/papers/3542269PubMed
3539384Comparative nephrotoxicity of carboplatin and cisplatin in combination with tobramycin.Cancer Chemother Pharmacol1986https://conductscience.org/library/papers/3539384PubMed
3436343Influence of frusemide on cis-dichlorodiammineplatinum (II) pharmaco-kinetics.Eur J Drug Metab Pharmacokinet1987https://conductscience.org/library/papers/3436343PubMed
2909288Evaluation of the effect of furosemide on ultrafilterable platinum kinetics in patients treated with cis-diamminedichloroplatinum.Cancer Chemother Pharmacol1989https://conductscience.org/library/papers/2909288PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/118952

GET https://conductscience.org/api/papers/v1/118952/authors